RECRUITING

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therapy. These could help manage prostate cancer. Researchers want to study how imaging can provide a profile of prostate cancer. They want to collect data to make diagnosis and treatments better. Objectives: To gather data about the radiological and clinical course of prostate cancer. To study imaging-based biomarkers of prostate cancer. Eligibility: Men ages 18 and older with diagnosed or suspected prostate cancer Design: Participants will give permission for researchers to use their medical history and records. Their data will be reviewed, collected, and analyzed. These include results of their tests and scans. Sponsoring Institution: National Cancer Institute

Official Title

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Quick Facts

Study Start:2018-02-26
Study Completion:2033-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03354416

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with an increased risk for prostate cancer (strong family history and/or germline mutation in DNA repair genes), or with a diagnosis of prostatic cancer or suspicious for prostatic cancer lesions.
  2. * Age greater than or equal to 18 years
  3. * Ability of subject to understand and the willingness to sign a written informed consent document.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Yolanda McKinney, R.N.
CONTACT
(240) 760-6095
ymckinney@mail.nih.gov
Ismail B Turkbey, M.D.
CONTACT
(240) 760-6112
turkbeyi@mail.nih.gov

Principal Investigator

Ismail B Turkbey, M.D.
PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)

Study Locations (Sites)

National Institutes of Health Clinical Center
Bethesda, Maryland, 20892
United States

Collaborators and Investigators

Sponsor: National Cancer Institute (NCI)

  • Ismail B Turkbey, M.D., PRINCIPAL_INVESTIGATOR, National Cancer Institute (NCI)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-02-26
Study Completion Date2033-12-31

Study Record Updates

Study Start Date2018-02-26
Study Completion Date2033-12-31

Terms related to this study

Keywords Provided by Researchers

  • Imaging-Based Prognostic Markers
  • Multiparametric MRI (mpMRI)
  • Translation of Imaging into Treatment Decisions
  • Decision-Support System
  • Artificial Intelligence Research
  • Natural History

Additional Relevant MeSH Terms

  • Prostatic Cancer
  • Prostatic Neoplams
  • Prostatic Hyperplasia
  • Prostate Cancer
  • Cancer Of Prostate